Smooth muscle α-actin deficiency leads to decreased liver fibrosis via impaired cytoskeletal signaling in hepatic stellate cells
American Journal of Pathology Sep 10, 2019
Rockey DC, et al. - Researchers focused on the association between smooth muscle α-actin (SM α-actin) and type 1 collagen expression (COL1A1), a major extracellular matrix protein significant in liver fibrosis and illustrated that knockout of SM α-actin results in decreased liver fibrosis and COL1 expression. The mechanism for the decrease in fibrogenesis in vivo is multifactorial, including not only a decline in the number of hepatic stellate cells (HSCs) but also HSC specific decrease in COL1 expression in Acta2 deficient HSCs. Irrespective of a compensatory rise in expression of cytoplasmic β-actin and γ-actin isoforms in Acta2-/- HSCs, defects were recognized in each transforming growth factor-beta/Smad2/3 and ET-1/Erk1/2 signaling in Acta2-/- HSCs. Thus, these data not only suggest a molecular link between the SM α-actin cytoskeleton and classic fibrogenic signaling cascades however, it also highlights the correlation between SM α-actin and fibrogenesis in hepatic myofibroblasts in vivo.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries